NCT00686803View on ClinicalTrials.gov

Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Hypertension
Interventions
DRUG

PL3994

Study drug

DRUG

Placebo

Placebo

Sponsors
All Listed Sponsors
lead

Palatin Technologies, Inc

INDUSTRY